Brief Report: Estimating Disease Activity Using Multi‐Biomarker Disease Activity Scores in Rheumatoid Arthritis Patients Treated With Abatacept or Adalimumab - Fleischmann, Roy; Connolly, Sean E.; Maldonado, Michael A.; Schiff, Michael (Arthritis & rheumatology (Hoboken, N.J.), 2016)
Keywords: Abatacept - therapeutic use; Adalimumab - therapeutic use; Antirheumatic Agents - therapeutic use; Arthritis, Rheumatoid - blood; Arthritis, Rheumatoid - drug therapy; Biomarkers - blood; Colon; Health risk assessment; Humans; Methotrexate; Rheumatoid Arthritis; Severity of Illness Index